CLOROX CO /DE/ - Common Stock (CLX)

Historical Holders from Q1 2014 to Q4 2025

Symbol
CLX on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
122,893,123
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
103,206,091
Holdings value
$12,717,815,390
% of all portfolios
0.01%
Number of holders
1,069
Number of buys
473
Number of sells
531
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CLOROX CO /DE/ - Common Stock (CLX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.1% -14% $1,195,217,964 -$205,050,863 9,954,343 -15% BlackRock, Inc. 30 Jun 2025
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.9% $148,823,364 1,081,801 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 31 Dec 2024
As of 30 Sep 2025 CLOROX CO /DE/ - Common Stock (CLX) has 1,069 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 103,206,091 shares of 122,893,123 outstanding shares and own 84% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of CLOROX CO /DE/ - Common Stock (CLX) own 59% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
VANGUARD GROUP INC 13% $1,940,579,368 15,738,681 -0.67%
BlackRock, Inc. 8.4% $1,280,221,037 10,382,977 -1.2%
STATE STREET CORP 6.9% $1,039,946,354 8,434,277 +3.5%
Invesco Ltd. 3.3% $492,656,204 3,995,590 +23%
MORGAN STANLEY 2.6% $394,044,241 3,195,815 +18%
GEODE CAPITAL MANAGEMENT, LLC 2.6% $388,302,573 3,162,173 +0.69%
STIFEL FINANCIAL CORP 2.5% $374,490,155 3,037,195 +25%
VAN ECK ASSOCIATES CORP 2.2% $334,139,000 2,709,972 +94%
TWO SIGMA ADVISERS, LP 1.7% $250,866,180 2,034,600 +181%
ROYAL BANK OF CANADA 1.5% $221,503,000 1,796,463 -1.5%
TWO SIGMA INVESTMENTS, LP 1.4% $214,563,577 1,740,175 +34%
NORTHERN TRUST CORP 1.3% $189,759,440 1,539,006 +4.8%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.2% $182,105,839 1,476,933 +18%
BANK OF AMERICA CORP /DE/ 1.2% $180,689,489 1,465,446 +31%
UBS Group AG 1.1% $167,365,941 1,357,388 -25%
ProShare Advisors LLC 1.1% $159,922,075 1,297,016 +12%
GOLDMAN SACHS GROUP INC 0.96% $145,378,527 1,179,063 +106%
Qube Research & Technologies Ltd 0.89% $134,960,358 1,094,569 -54%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.88% $134,083,571 1,087,458 +44%
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.86% $130,490,856 1,058,320 -18%
Legal & General Group Plc 0.84% $127,528,583 1,034,295 +2.6%
Bank of New York Mellon Corp 0.77% $117,063,600 949,421 +5.8%
CONFLUENCE INVESTMENT MANAGEMENT LLC 0.76% $114,803,803 931,093 -1.1%
JPMORGAN CHASE & CO 0.76% $114,506,445 928,654 +27%
DIMENSIONAL FUND ADVISORS LP 0.7% $105,968,602 859,459 -1.1%

Institutional Holders of CLOROX CO /DE/ - Common Stock (CLX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 829,397 $83,628,241 -$11,690,878 $100.83 10
2025 Q3 103,206,091 $12,717,815,390 -$583,290,695 $123.30 1,069
2025 Q2 108,595,055 $13,040,489,607 +$1,045,401,428 $120.07 1,109
2025 Q1 99,182,853 $14,603,595,865 -$198,929,360 $147.25 1,167
2024 Q4 99,962,125 $16,229,831,868 +$163,757,502 $162.41 1,208
2024 Q3 99,085,600 $16,145,004,443 -$344,560,640 $162.91 1,142
2024 Q2 101,212,464 $13,809,244,007 +$297,871,328 $136.47 1,081
2024 Q1 98,877,796 $15,127,669,963 +$94,250,531 $153.11 1,128
2023 Q4 98,215,382 $14,002,412,284 -$129,819,056 $142.59 1,097
2023 Q3 98,611,478 $12,912,635,677 +$64,825,477 $131.06 1,048
2023 Q2 97,540,537 $15,510,556,843 -$325,402,136 $159.04 1,128
2023 Q1 99,507,323 $15,739,622,817 +$65,037,563 $158.24 1,126
2022 Q4 99,471,271 $13,961,189,365 +$149,277,608 $140.33 1,090
2022 Q3 98,541,245 $12,663,956,923 -$186,693,813 $128.39 1,026
2022 Q2 99,798,675 $14,069,491,146 +$621,111,459 $140.98 1,061
2022 Q1 95,439,925 $13,268,194,190 -$57,855,916 $139.03 1,072
2021 Q4 94,968,802 $16,548,766,330 -$150,678,134 $174.36 1,204
2021 Q3 95,267,361 $15,766,921,498 -$6,706,488 $165.61 1,115
2021 Q2 95,297,294 $17,128,818,735 -$457,185,366 $179.91 1,151
2021 Q1 98,120,182 $18,911,351,854 -$1,124,134,994 $192.88 1,192
2020 Q4 104,219,730 $21,017,735,125 -$246,770,648 $201.92 1,244
2020 Q3 105,428,088 $22,133,537,855 +$1,061,014,461 $210.17 1,195
2020 Q2 100,006,774 $21,920,532,250 +$108,770,932 $219.37 1,185
2020 Q1 100,129,985 $17,352,607,183 +$58,205,966 $173.25 1,108
2019 Q4 99,634,890 $15,300,054,566 +$144,398,204 $153.54 1,013
2019 Q3 98,409,693 $14,946,614,586 -$142,837,937 $151.87 966
2019 Q2 99,406,731 $15,211,858,183 +$7,430,687 $153.11 955
2019 Q1 100,100,612 $16,038,407,073 +$187,587,615 $160.46 1,004
2018 Q4 98,745,799 $15,199,255,988 -$330,097,182 $154.14 977
2018 Q3 100,616,702 $15,110,827,729 -$95,739,179 $150.41 926
2018 Q2 101,403,293 $13,685,309,299 +$505,456,635 $135.25 908
2018 Q1 98,798,121 $13,103,444,236 +$85,356,741 $133.11 905
2017 Q4 98,622,456 $14,621,687,857 +$403,878,995 $148.74 922
2017 Q3 95,063,859 $12,536,984,167 +$321,521,923 $131.91 852
2017 Q2 92,702,892 $12,351,173,039 +$179,226,340 $133.24 863
2017 Q1 91,942,125 $12,384,961,332 +$1,397,150,385 $134.83 854
2016 Q4 91,141,955 $10,932,867,745 -$79,776,726 $120.02 836
2016 Q3 91,037,903 $11,389,661,951 -$115,775,955 $125.18 817
2016 Q2 91,758,877 $12,694,474,319 +$32,430,363 $138.39 837
2016 Q1 91,840,086 $11,574,271,852 -$8,864,617 $126.06 845
2015 Q4 91,876,836 $11,653,646,093 -$257,475,500 $126.83 828
2015 Q3 93,640,376 $10,816,232,588 -$32,714,351 $115.53 769
2015 Q2 94,039,968 $9,784,855,686 -$21,201,966 $104.02 735
2015 Q1 94,152,866 $10,390,168,956 -$97,612,298 $110.39 736
2014 Q4 95,346,075 $9,940,145,755 -$47,331,190 $104.21 727
2014 Q3 95,930,304 $9,213,147,257 -$74,717,334 $96.04 668
2014 Q2 96,784,212 $8,845,650,707 +$62,169,605 $91.40 664
2014 Q1 96,302,468 $8,476,425,024 -$143,491,913 $88.01 651